Trial Profile
A pilot program to evaluate Probuphine (buprenorphine) implant for Opioid Use Disorder (OUD) patients within the State of Nevada criminal justice system
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2018
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 16 Sep 2018 New trial record
- 04 Sep 2018 According to a Titan Pharmaceuticals media release, the company has initiated this program in collaboration with the Nevada Center for Behavioral Health (NCBH).